Media headlines about Surgery Partners (NASDAQ:SGRY) have trended somewhat positive on Saturday, according to Accern. The research group rates the sentiment of media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Surgery Partners earned a daily sentiment score of 0.17 on Accern’s scale. Accern also assigned news stories about the company an impact score of 46.1900923926154 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

These are some of the media headlines that may have impacted Accern Sentiment Analysis’s scoring:

Several equities research analysts have recently weighed in on the company. ValuEngine downgraded Surgery Partners from a “hold” rating to a “sell” rating in a report on Friday, February 2nd. Zacks Investment Research downgraded Surgery Partners from a “hold” rating to a “sell” rating in a report on Tuesday, February 6th. Benchmark set a $19.00 price objective on Surgery Partners and gave the company a “buy” rating in a report on Tuesday, January 30th. Royal Bank of Canada reissued a “buy” rating and issued a $18.00 price objective on shares of Surgery Partners in a report on Sunday, November 12th. Finally, BidaskClub raised Surgery Partners from a “hold” rating to a “buy” rating in a report on Wednesday, February 21st. Three research analysts have rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the stock. Surgery Partners currently has an average rating of “Hold” and an average target price of $18.57.

Shares of Surgery Partners (SGRY) opened at $16.00 on Friday. The company has a current ratio of 2.09, a quick ratio of 1.92 and a debt-to-equity ratio of 1.56. Surgery Partners has a fifty-two week low of $7.10 and a fifty-two week high of $24.05. The firm has a market capitalization of $729.10, a price-to-earnings ratio of -34.78 and a beta of 2.10.

Surgery Partners announced that its Board of Directors has authorized a stock buyback program on Friday, December 15th that authorizes the company to buyback $50.00 million in shares. This buyback authorization authorizes the company to repurchase shares of its stock through open market purchases. Shares buyback programs are typically an indication that the company’s board of directors believes its shares are undervalued.

ILLEGAL ACTIVITY WARNING: “Surgery Partners (SGRY) Earns Daily Media Sentiment Rating of 0.17” was first published by Watch List News and is the property of of Watch List News. If you are accessing this story on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this story can be read at

About Surgery Partners

Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.

Insider Buying and Selling by Quarter for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with's FREE daily email newsletter.